{
    "clinical_study": {
        "@rank": "52181", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die.\n\n      PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients with\n      recurrent oligodendroglial tumors."
        }, 
        "brief_title": "Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors", 
        "condition": "Brain and Central Nervous System Tumors", 
        "condition_browse": {
            "mesh_term": [
                "Nervous System Neoplasms", 
                "Central Nervous System Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Assess the therapeutic activity of temozolomide as first line chemotherapy in\n      patients with recurrent oligodendroglial tumors after radiation therapy. II. Assess the\n      objective response and duration of response of these patients given this treatment. III.\n      Characterize the acute side effects of temozolomide in this patient population.\n\n      OUTLINE: This is an open label, multicenter study. Patients receive oral temozolomide on\n      days 1-5. Courses are repeated every 28 days. Treatment continues for a maximum of 12\n      courses in the absence of unacceptable toxicity or disease progression. Patients are\n      followed every 3 months until disease progression.\n\n      PROJECTED ACCRUAL: A total of 15-33 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically proven oligodendroglioma or oligoastrocytoma with\n        at least 25% oligodendroglial elements Recurrent or progressive disease following\n        radiotherapy At least 3 months since prior radiotherapy Measurable disease by MRI or CT\n        scan Lesion must have a diameter of at least 1 cm No progressive neurological deficits\n        from the present recurrence No new neurological deficits interfering with daily activities\n        No tumor causing midline shift or brain stem compression due to which a rapid\n        deterioration is to be expected in case of no response No signs of increased intracranial\n        pressure No extracranial disease\n\n        PATIENT CHARACTERISTICS: Age: 18 to 70 Performance status: WHO 0-2 Life expectancy: At\n        least 3 months Hematopoietic: Neutrophil count at least 1,500/mm3 Platelet count at least\n        100,000/mm3 Hepatic: Bilirubin no greater than 1.25 times upper limit of normal (ULN)\n        AST/ALT no greater than 2 times ULN Alkaline phosphatase no greater than 2 times ULN\n        Renal: Creatinine clearance at least 60 mL/min Creatinine no greater than 1.25 times ULN\n        Neurologic: See Disease Characteristics Other: Not pregnant or nursing Fertile patients\n        must use effective contraception No other malignant or nonmalignant diseases interfering\n        with follow-up No psychological, familial, sociological, or geographical condition\n        potentially hampering compliance with the study and follow-up\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior\n        chemotherapy Endocrine therapy: Not specified Radiotherapy: See Disease Characteristics\n        Surgery: Not specified Other: No other concurrent investigational drugs No other\n        concurrent antitumor agents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "39", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003731", 
            "org_study_id": "EORTC-26971", 
            "secondary_id": "EORTC-26971"
        }, 
        "intervention": {
            "intervention_name": "temozolomide", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Temozolomide", 
                "Dacarbazine"
            ]
        }, 
        "keyword": [
            "adult oligodendroglioma", 
            "adult mixed glioma"
        ], 
        "lastchanged_date": "September 20, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-26971"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1090"
                    }, 
                    "name": "Academisch Ziekenhuis der Vrije Universiteit Brussel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1070"
                    }, 
                    "name": "Hopital Universitaire Erasme"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Centre Hospitalier Regional de Lille"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13385"
                    }, 
                    "name": "CHU de la Timone"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France", 
                        "zip": "54035"
                    }, 
                    "name": "CHU de Nancy - Hopital Neurologique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06002"
                    }, 
                    "name": "Hopital Pasteur"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06189"
                    }, 
                    "name": "Centre Antoine Lacassagne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bamberg", 
                        "country": "Germany", 
                        "zip": "D-96049"
                    }, 
                    "name": "Nervenklinik Bamberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "D-12200"
                    }, 
                    "name": "Universitaetsklinikum Benjamin Franklin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Regensburg", 
                        "country": "Germany", 
                        "zip": "DOH-9-3053"
                    }, 
                    "name": "Klinikum der Universitat Regensburg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova (Padua)", 
                        "country": "Italy", 
                        "zip": "35128"
                    }, 
                    "name": "Azienda Ospedaliera di Padova"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy", 
                        "zip": "00161"
                    }, 
                    "name": "Istituti Fisioterapici Ospitalieri - Roma"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6252 HB"
                    }, 
                    "name": "University Medical Center Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3075 EA"
                    }, 
                    "name": "Rotterdam Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3508 GA"
                    }, 
                    "name": "Academisch Ziekenhuis Utrecht"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisbon", 
                        "country": "Portugal", 
                        "zip": "1093"
                    }, 
                    "name": "Instituto Portugues de Oncologia de Francisco Gentil"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bratislava", 
                        "country": "Slovakia", 
                        "zip": "833 03"
                    }, 
                    "name": "Postgraduate Medical Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarau", 
                        "country": "Switzerland", 
                        "zip": "5001"
                    }, 
                    "name": "Kantonspital Aarau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH-4031"
                    }, 
                    "name": "University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "zip": "CH-3010"
                    }, 
                    "name": "Inselspital, Bern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "CH-1011"
                    }, 
                    "name": "Centre Hospitalier Universitaire Vaudois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edinburgh", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "EH4 9NQ"
                    }, 
                    "name": "Western General Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "France", 
                "Germany", 
                "Italy", 
                "Netherlands", 
                "Portugal", 
                "Slovakia", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "official_title": "First Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors, a Phase II Trial", 
        "overall_official": {
            "affiliation": "Daniel Den Hoed Cancer Center at Erasmus Medical Center", 
            "last_name": "Martin J. van Den Bent, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2001", 
            "@type": "Actual"
        }, 
        "reference": {
            "PMID": "16914310", 
            "citation": "Kouwenhoven MC, Kros JM, French PJ, Biemond-ter Stege EM, Graveland WJ, Taphoorn MJ, Brandes AA, van den Bent MJ. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. Eur J Cancer. 2006 Oct;42(15):2499-503. Epub 2006 Aug 17."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003731"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "citation": "van den Bent MJ, Taphoorn MJ, Brandes AA, et al.: EORTC brain tumor group study 26971: first line chemotherapy with temozolomide in recurrent oligodendroglial tumors; a phase II study. [Abstract] Proceedings of the American Society of Clinical Oncology 21: A-285, 2002."
        }, 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 1998", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }, 
    "geocoordinates": {
        "Academisch Ziekenhuis Utrecht": "52.09 5.11", 
        "Academisch Ziekenhuis der Vrije Universiteit Brussel": "50.85 4.352", 
        "Azienda Ospedaliera di Padova": "45.41 11.877", 
        "CHU de Nancy - Hopital Neurologique": "48.692 6.184", 
        "CHU de la Timone": "43.296 5.37", 
        "Centre Antoine Lacassagne": "43.696 7.266", 
        "Centre Hospitalier Regional de Lille": "50.629 3.057", 
        "Centre Hospitalier Universitaire Vaudois": "46.52 6.634", 
        "Hopital Pasteur": "43.696 7.266", 
        "Hopital Universitaire Erasme": "50.85 4.352", 
        "Inselspital, Bern": "46.948 7.445", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Instituto Portugues de Oncologia de Francisco Gentil": "38.707 -9.136", 
        "Istituti Fisioterapici Ospitalieri - Roma": "41.891 12.494", 
        "Kantonspital Aarau": "47.391 8.046", 
        "Klinikum der Universitat Regensburg": "49.015 12.101", 
        "Nervenklinik Bamberg": "49.899 10.903", 
        "Postgraduate Medical Institute": "48.146 17.107", 
        "Rotterdam Cancer Institute": "51.924 4.482", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Universitaetsklinikum Benjamin Franklin": "52.524 13.406", 
        "University Hospital": "47.557 7.593", 
        "University Medical Center Nijmegen": "51.843 5.855", 
        "Western General Hospital": "55.953 -3.188"
    }
}